Dong-E-E-Jiao Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dong-E-E-Jiao Co Ltd with three other
companies in this sector in China:
Livzon Pharmaceutical Group Incorporated
sales of 8.53 billion Chinese Renmimbi [US$1.34 billion]
of which 43%
was Western Medicine),
North China Pharmaceutical, Limited
(7.71 billion Chinese Renmimbi [US$1.21 billion]
of which 50%
was Chemical Preparation Medicine), and
Shanghai Shyndec Pharmaceutical Co Ltd
(8.52 billion Chinese Renmimbi [US$1.34 billion]
of which 60%
was Drug Products).
Dong-E-E-Jiao Co Ltd reported sales of 7.37 billion Chinese Renmimbi (US$1.16 billion)
December of 2017.
increase of 16.7%
versus 2016, when the company's sales were 6.32 billion Chinese Renmimbi.
This was the third consecutive year of growth at Dong-E-E-Jiao Co Ltd.
Sales of Other Business saw an increase
that was more than double the company's growth rate: sales were up
125.2% in 2017, from
12.18 million Chinese Renmimbi to 27.42 million Chinese Renmimbi.
Dong-E-E-Jiao Co Ltd also saw significant increases in sales in
Other (up 89.2% to 791.03 million Chinese Renmimbi)
Not all segments of Dong-E-E-Jiao Co Ltd experienced an increase in sales in 2017:
sales of Medicine Trade fell 48.7% to 136.31 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).